Targeting NF-kB by Natural Products in the Management of vascular Complications of Diabetes

Zapisane w:

Opis bibliograficzny
1. autor:	Sachin Suryavanshi
Format:	Praca dyplomowa Książka
Język:	angielski
Wydane:	2021
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy

Targeting NF-κβ by natural Products in the Management of Vascular Complications of Diabetes
od: Suryavanshi Sachin Vilas
Wydane: (2021)

STUDY OF NATURALLY OCCURING FLAVONES IN THE TREATMENT OF VASCULAR COMPLICATIONS OF DIABETES
od: PARKAR NISHAD

Study of Naturally Occurring Flavones in the Treatment of Vascular Complications of Diabetes
od: Parkar Nishad
Wydane: (2014)

NF- kB : A netwok Hub Controlling Immunity Inflamation & Cancer
od: Karin Michael, Staud L M
Wydane: (2010)

Targeting SIRTI By Isoflavone for the Treatment of Type 2 Diabetes and its Complications
od: Oza Manisha
Wydane: (2019)

Targeting SIRT1 by Isoflavone for the Treatment of Type 2 Diabetes and its Complications
od: Manisha Oza

Preclinical Studies of Daidzein in the Treatment of Diabetic Complications
od: Ankit Laddha
Wydane: (2021)

Preclinical Studies on Daidzein in the Treatment of Diabetic Complications
od: Laddha Ankit P.
Wydane: (2021)

Complications
od: Gawande, Atul
Wydane: (2014)

Taxonomy of vascular plants
od: Lawrence, G
Wydane: (1967)

Taxonomy of vascular plants
od: Lawrence, H

Complications: Notes from the Life of Young Surgeon
od: Gawande, Atul
Wydane: (2002)

Complications: A Surgeon's Notes on an Imperfect Science
od: Gawande, Atul
Wydane: (2014)

NEW THERAPEUTIC STRATEGICS FOR THE TREATMENT OF DIABETIC COMPLICATIONS WITH COMORBID DISEASE CONDITIONS
od: BHATT LOKESH KUMAR

Therapeutic Potential of Beta-Caryophyllene Combined with L-Arginine in the Management of Diabetic Complications
od: Vivek Kumawat

Therapeutic Potential of Beta-Caryophyllene Combined with L-Arginine in the Management of Diabetic Complications
od: Kumawat Vivek S.
Wydane: (2023)

Law Of Criminal Complicity
od: Gillis, Peter
Wydane: (1980)

New Therapeutic Strategies for the Treatment of Macrovascular and Macrovascular Diabetic Complications with Comorbid Dise
od: Bhatt, Lokeshkumar
Wydane: (2010)

Pharmaceutical Chemistry of Natural Products
od: Todkar, Sachin S.
Wydane: (2017)

Diabetes
od: Krishnamurthy, H M
Wydane: (2003)

Diabetes
od: DoctorNDTV.Com
Wydane: (2010)

Botany For Degree Students : Pteridophyta (Vascular Cryptogams)
od: Vashishta P.C
Wydane: (2022)

USP NF 2006
od: United States Pharmacopeial Convention
Wydane: (2006)

USP NF:1
od: UNITED STATES PHARMACOPEIAL CONVENTION

USP NF : 2
od: UNITED STATES PHARMACOPEIAL CONVENTION

USP NF :2
od: UNITED STATES PHARMACOPEIAL CONVENTION

Bhattacharjee, B.K.
od: Industrial arts of india
Wydane: (1998)

Diabetic cardiomyopathy
od: Turan, Belma
Wydane: (2014)

LIFE WITH DIABETES
od: BLOOM A
Wydane: (1988)

Diabetes Control
od: Sathi A.k
Wydane: (2003)

Diabetes Rising
od: Dan Hurley
Wydane: (2011)

THE DIABETIC COOKBOOK
od: SWAMY MICHAEL
Wydane: (2024)

Natural products
od: Brahmachari, G.
Wydane: (2009)

Natural products
od: Brahmachari, G
Wydane: (2009)

USP NF:1 SUPPLEMENT
od: UNITED STATES PHARMACOPEIAL CONVENTION

Preclinical Studies on Herbal Extract and Phytochemical as Monocyte Chemoattractant Protein-1 (MCP-1) Inhibitor for Diabetic Complications
od: Kaveri Adki

Preclinical Studies on Herbal Extract and Phytochemical as Monocyte Chemoattractant Protein-1 (MCP - 1) Inhibitor in Diabetic Complications
od: Adki Kaveri M.
Wydane: (2023)

Say No to Diabetes Use Natural Supplements to reduce risk & insulin dependency
od: Murray, Frank

Complications: a surgeon's notes on an imperfect science
od: Gawande, Atul

Thing Explainer: Complicated Stuff In Simple Words
od: Munroe Randall
Wydane: (2015)